To address unmet needs in the treatment of type 2 diabetes in Korea, we have decided to initiate domestic supply prior to reimbursement approval, thereby expanding treatment options for healthcare providers and ensuring patients can fully benefit from the therapy." The official added, To further enhance patient access to treatment, we are in close consultation with relevant authorities with the goal of securing prompt national health insurance coverage approval for Ozempic. Eli Lilly's competing drug, Mounjaro (tirzepatide), is also currently undergoing review for national health insurance coverage for its type 2 diabetes indication
McCoy, Jeph Herrin, Kavya Sindhu Swarna, Yihong Deng, David M
doi:10.1152/ajpheart.00708.2019 Pirillo A, Norata GD
If Planet Fitness is the low-end of the gym industrys GLP-1 absorption strategy, Life Time is the high end, and Life Time has been more aggressive